Phio Pharmaceuticals Corp.

NasdaqCM:PHIO Stock Report

Mkt Cap: US$7.1m

Phio Pharmaceuticals Management

How experienced are the management team and are they aligned to shareholders interests?

6.0yrs

Average board tenure


CEO

Geert Cauwenbergh (68 yo)

10.83yrs

Tenure

US$58,300

Compensation

Dr. Geert Cauwenbergh, Ph D., Dr., Med Sc., has been a Director of Phio Pharmaceuticals Corp. (formerly known as RXi Pharmaceuticals Corporation) since April 2012 and as its Interim Principal Executive and...


CEO Compensation Analysis

How has Geert Cauwenbergh's remuneration changed compared to Phio Pharmaceuticals's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a

-US$12m

Jun 30 2022n/an/a

-US$12m

Mar 31 2022n/an/a

-US$13m

Dec 31 2021US$58kn/a

-US$13m

Sep 30 2021n/an/a

-US$12m

Jun 30 2021n/an/a

-US$11m

Mar 31 2021n/an/a

-US$10m

Dec 31 2020US$27kn/a

-US$9m

Sep 30 2020n/an/a

-US$9m

Jun 30 2020n/an/a

-US$9m

Mar 31 2020n/an/a

-US$9m

Dec 31 2019US$901kUS$132k

-US$9m

Sep 30 2019n/an/a

-US$8m

Jun 30 2019n/an/a

-US$7m

Mar 31 2019n/an/a

-US$7m

Dec 31 2018US$610kUS$420k

-US$7m

Sep 30 2018n/an/a

-US$8m

Jun 30 2018n/an/a

-US$9m

Mar 31 2018n/an/a

-US$9m

Dec 31 2017US$579kUS$416k

-US$12m

Sep 30 2017n/an/a

-US$15m

Jun 30 2017n/an/a

-US$15m

Mar 31 2017n/an/a

-US$14m

Dec 31 2016US$639kUS$414k

-US$11m

Compensation vs Market: Geert's total compensation ($USD58.30K) is below average for companies of similar size in the US market ($USD730.59K).

Compensation vs Earnings: Geert's compensation has increased whilst the company is unprofitable.


Board Members

NamePositionTenureCompensationOwnership
Robert Bitterman
Executive Chairman10.67yrsUS$78.30k0.18%
$ 12.7k
Geert Cauwenbergh
Interim Principal Executive & Financial Officer and Director10.83yrsUS$58.30k0.17%
$ 11.8k
Patricia Bradford
Independent Director0.83yrno datano data
James Griffin
Member of Scientific Advisory Board6yrsno datano data
Curtis Lockshin
Independent Director9.83yrsUS$65.80k0.076%
$ 5.4k
Pamela Pavco
Member of Scientific Advisory Board5.75yrsno datano data
Rolf Kiessling
Member of Scientific Advisory Board6yrsno datano data
Robert Ferrara
Lead Independent Director3.33yrsUS$73.30k0.15%
$ 10.4k
Jonathan Freeman
Independent Director5.67yrsUS$58.30k0.076%
$ 5.4k

6.0yrs

Average Tenure

69.5yo

Average Age

Experienced Board: PHIO's board of directors are considered experienced (6 years average tenure).